PatentJul 16, 2026, 08:31 AM
Nuwellis Receives Patent for Dual Lumen Catheter
AI Summary
Nuwellis, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,678,592 for its Dual Lumen Catheter. This novel peripheral catheter is designed for extracorporeal therapies like ultrafiltration and dialysis, featuring a reinforcing stainless-steel coil to prevent collapse and allowing for customizable length. The patent strengthens Nuwellis' intellectual property and aims to address clinical challenges by improving therapy performance and flexibility for patients.
Key Highlights
- U.S. Patent No. 12,678,592 was issued by the USPTO on July 14, 2026.
- The patent covers Nuwellis' novel Dual Lumen Catheter for extracorporeal therapies.
- The catheter is designed for ultrafiltration, dialysis, and continuous renal replacement therapy (CRRT).
- It features a reinforcing stainless-steel coil to maintain patency under negative pressure.
- The design allows clinicians to trim the catheter to customize length without compromising structural integrity.
- The innovation aims to improve blood flow, support longer filter life, and offer flexibility for varying patient sizes.
- The patent expands Nuwellis' intellectual property portfolio and supports its strategy in cardiorenal conditions.
Price Impact
More from NUWE